1![From bloodjournal.hematologylibrary.org at Dana-Farber Cancer Institute on March 24, 2014. For personal use only: Prepublished online January 2, 2014; doi:blood From bloodjournal.hematologylibrary.org at Dana-Farber Cancer Institute on March 24, 2014. For personal use only: Prepublished online January 2, 2014; doi:blood](https://www.pdfsearch.io/img/f6b1cc33cfacbc4e6c40a9bbee3fee46.jpg) | Add to Reading ListSource URL: michorlab.dfci.harvard.eduLanguage: English - Date: 2014-03-24 13:50:21
|
---|
2![reprinted from junepathology ◆ laboratory medicine ◆ laboratory management Using molecular techniques to confirm donorderived post-transplant lymphoproliferative disorder (diffuse large B-cell lymphoma of CNS) reprinted from junepathology ◆ laboratory medicine ◆ laboratory management Using molecular techniques to confirm donorderived post-transplant lymphoproliferative disorder (diffuse large B-cell lymphoma of CNS)](https://www.pdfsearch.io/img/0e98e5fe0af2edb24646cdc9c01e1dea.jpg) | Add to Reading ListSource URL: www.amp.orgLanguage: English - Date: 2014-07-02 13:15:28
|
---|
3![AACR2015 CUDC-427 Hema poster AACR2015 CUDC-427 Hema poster](https://www.pdfsearch.io/img/5aaee9b2714e060af7e2e273a5860a16.jpg) | Add to Reading ListSource URL: www.curis.comLanguage: English - Date: 2015-04-21 09:23:42
|
---|
4![ProNAi Therapeutics Reports Anti-Tumor Activity from Ongoing Phase II Clinical Study of PNT2258, a Novel BCL2-Inhibitor, at ASH Annual Meeting December 09, :00 PM Eastern Standard Time ASH 2013 PLYMOUTH, Mich.--(B ProNAi Therapeutics Reports Anti-Tumor Activity from Ongoing Phase II Clinical Study of PNT2258, a Novel BCL2-Inhibitor, at ASH Annual Meeting December 09, :00 PM Eastern Standard Time ASH 2013 PLYMOUTH, Mich.--(B](https://www.pdfsearch.io/img/4738526ac0896cdd5b0e12cba7496af0.jpg) | Add to Reading ListSource URL: www.apjohnventures.comLanguage: English - Date: 2014-01-07 14:36:35
|
---|
5![Targeting their Interaction with the IP3 Receptors: New Tools to Overcome Bcl-2 Proteins-Associated Drug Resistance NOUGARÈDE Adrien ; RIMOKH Ruth ; GILLET Germain Centre de recherche en cancérologie de Lyon, U1052 INS Targeting their Interaction with the IP3 Receptors: New Tools to Overcome Bcl-2 Proteins-Associated Drug Resistance NOUGARÈDE Adrien ; RIMOKH Ruth ; GILLET Germain Centre de recherche en cancérologie de Lyon, U1052 INS](https://www.pdfsearch.io/img/06dea3370635a1e11118a3929af44710.jpg) | Add to Reading ListSource URL: www.canceropole-clara.comLanguage: English - Date: 2015-04-10 05:44:22
|
---|
6![IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2 IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2](https://www.pdfsearch.io/img/33d2ba77e0787b2b2c6984459954e352.jpg) | Add to Reading ListSource URL: www.nature.comLanguage: English - Date: 2014-07-18 10:44:40
|
---|
7![Mcl-1 levels need not be lowered for cells to be sensitized for ABT-263/737-induced apoptosis Mcl-1 levels need not be lowered for cells to be sensitized for ABT-263/737-induced apoptosis](https://www.pdfsearch.io/img/8fc04fc98c195840f68b7bb3659db831.jpg) | Add to Reading ListSource URL: www.nature.comLanguage: English - Date: 2011-11-10 05:59:02
|
---|
8![ARTICLE Received 5 Apr 2011 | Accepted 20 Jun 2011 | Published 19 Jul 2011 DOI: [removed]ncomms1404 Functional and molecular interactions between ARTICLE Received 5 Apr 2011 | Accepted 20 Jun 2011 | Published 19 Jul 2011 DOI: [removed]ncomms1404 Functional and molecular interactions between](https://www.pdfsearch.io/img/e15bf2fbf2285a86009958f38a99277e.jpg) | Add to Reading ListSource URL: www.nature.comLanguage: English - Date: 2011-07-19 11:00:08
|
---|
9![Antibody drug conjugates (ADCs) Changing the direction of cancer treatment 1900s The concept of a targeted therapy to treat diseases such as cancer is conceived.1 Antibody drug conjugates (ADCs) Changing the direction of cancer treatment 1900s The concept of a targeted therapy to treat diseases such as cancer is conceived.1](https://www.pdfsearch.io/img/feb8937712a6a9c849048e21f8d9bde5.jpg) | Add to Reading ListSource URL: www.roche.comLanguage: English - Date: 2014-11-28 09:23:55
|
---|
10![Antibody drug conjugates (ADCs) Changing the direction of cancer treatment 1900s The concept of a targeted therapy to treat diseases such as cancer is conceived.1 Antibody drug conjugates (ADCs) Changing the direction of cancer treatment 1900s The concept of a targeted therapy to treat diseases such as cancer is conceived.1](https://www.pdfsearch.io/img/1c335037b5becb078e6309806a758067.jpg) | Add to Reading ListSource URL: www.roche.comLanguage: English - Date: 2014-11-28 09:23:55
|
---|